Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.71K Hold
32
﹤0.01% 340
2026
Q1
$1.79K Hold
32
﹤0.01% 347
2025
Q4
$1.59K Hold
32
﹤0.01% 276
2025
Q3
$1.39K Hold
32
﹤0.01% 273
2025
Q2
$1.21K Hold
32
﹤0.01% 278
2025
Q1
$1.24K Hold
32
﹤0.01% 283
2024
Q4
$1.08K Buy
+32
New +$1.15K ﹤0.01% 289

Other funds holding GSK

Holos Integrated Wealth's GSK Position: Q2 2026 in Review

Holos Integrated Wealth held its GSK (GSK) position steady in Q2 2026 at 32 shares worth $1.71K. The position accounts for ﹤0.01% of the portfolio, ranked #340.

Holos Integrated Wealth first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.79K in Q1 2026. 283 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Holos Integrated Wealth held 32 shares of GSK worth $1.71K as of Q2 2026.
  • Holos Integrated Wealth left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of Holos Integrated Wealth's portfolio in Q2 2026, its #340 holding.
  • Holos Integrated Wealth first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • Holos Integrated Wealth's GSK position peaked at $1.79K in Q1 2026.
  • 283 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Holos Integrated Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.